CSGALNACT2 antibody (AA 200-229) (PE)

Catalog No. ABIN1975750

Product Details anti-CSGALNACT2 Antibody (PE)

Target: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Binding Specificity: AA 200-229

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CSGALNACT2 antibody is conjugated to PE

Application: ELISA, Western Blotting (WB)

Specificity: This CSGALNACT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-229 amino acids from the Central region of human CSGALNACT2.

Purification: Affinity purified

Isotype: IgG

Application Details

Application Notes: Approved: ELISA, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 0.09 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Aliquot to avoid repeated freezing and thawing.

Storage: 4 °C,-20 °C

Storage Comment: Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.

Expiry Date: 6 months

Target Details for CSGALNACT2

Target: CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))

Alternative Name: CSGALNACT2 (CSGALNACT2 Products)

Synonyms: CHGN2 antibody, GALNACT-2 antibody, GALNACT2 antibody, 4632415D10Rik antibody, Galnact2 antibody, RGD1563660 antibody, DKFZp459O0128 antibody, chondroitin sulfate N-acetylgalactosaminyltransferase 2 antibody, CSGALNACT2 antibody, Csgalnact2 antibody, csgalnact2 antibody

Background: Name/Gene ID: CSGALNACT2

Synonyms: CSGALNACT2, Beta4GalNAcT-2, GALNACT2, GALNACT-2, PRO0082, Beta 4 GalNAcT-2, CHGN2, Chondroitin sulfate GalNAcT-2

Gene ID: 55454

Pathways: Glycosaminoglycan Metabolic Process